Top Markets
Coin of the day
BioGend Therapeutics Co., Ltd. BioGend Therapeutics Co., Ltd.

BioGend Therapeutics Co., Ltd.

6733
Rangering i aksjer #21371
This company specializes in the development of innovative regenerative... This company specializes in the development of innovative regenerative bio-orthopedic products. Its current pipeline includes BiG-001 and BiG-006, both of which are osteoinductive bone graft substitutes. Additionally, it is advancing BiG-009, an autologous cartilage repair system. Established in 2016, the firm's operations are based in Taipei, Taiwan.
Aksjekurs
$0.81882497
Sist synkronisert: 2026-08-21
Markedsverdi
$108.85M
Endring (1 dag)
0.39%
Endring (1 år)
-38.35%
Land
TW
Handel BioGend Therapeutics Co., Ltd. (6733)

Kategori

Utbyttehistorikk for BioGend Therapeutics Co., Ltd. (6733)
BioGend Therapeutics Co., Ltd. (aksjesymbol: 6733) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for BioGend Therapeutics Co., Ltd. (6733) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter
Selskap Antall utbyttebetalinger Land
0.00%
US
0.00%
NL
0.00%
US
64.00%
AU
0.00%
CH